Skip to search formSkip to main contentSkip to account menu

VePesid-Ifosfamide-Platinol Regimen

Known as: VP16-Ifosfamide-Platinol Regimen, Etoposide-Ifosfamide-Cisplatin Regimen, VIP 
A regimen consisting of etoposide, ifosfamide and cisplatin used for the treatment of advanced-stage germ cell gonadal cancers.
National Institutes of Health

Related topics

Related topics

5 relations
CisplatinEtoposideIfosfamideTesticular malignant germ cell tumor

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Clinical Management and Outcome in Extreme Retroperitoneal Growing Teratoma Syndrome of Testicular Origin - Clinical Management and Effect of the Treatment.
BACKGROUND Growing teratoma syndrome (GTS) is an uncommon clinical finding in patients treated for testicular cancer. It is… 
2016
2016
Abstract CT081: High-dose chemotherapy associated with bevacizumab for metastatic germ cell tumors: the TAXIF 3 trial
Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA Germ cell tumors (GCT) are a model of curative… 
2007
2007
Hochdosischemotherapie und hämatopoetische Stammzelltransplantation bei Patienten mit Keimzelltumoren
ZusammenfassungUrologen erwägen bei Keimzelltumoren gemeinsam mit dem internistischen Onkologen zum richtigen Zeitpunkt eine… 
2002
2002
Treatment Strategy for Childhood Extracranial Secreting Germ Cell Tumours Based on Alphafoetoprotein (AFP) Level: Protocol TGM95 of the Société Française d’Oncologie Pédiatrique (SFOP)
The previous SFOP TGM85 and TGM90 studies showed that carboplatin (400 mg/m2) was less efficient that cisplatin (100 mg/m2), that… 
2000
2000
High-Dose Chemotherapy in Poor-Risk Germ-Cell Tumors
Testicular cancer is a highly curable cancer. However, 30% of patients are refractory to standard therapy and will need… 
1999
1999
Neoadjuvant etoposide, ifosfamide, and cisplatin followed by concomitant thoracic radiotherapy and continuous cisplatin infusion in stage IIIb non-small cell lung cancer.
OBJECTIVE To determine the applicability and safety of an ifosfamide, cisplatin, and etoposide (VIP) regimen as a neoadjuvant… 
1996
1996
A phase II trial of VP-16, ifosfamide, cisplatin, vinblastine, and bleomycin in advanced germ-cell tumors.
PURPOSE A Phase II study to evaluate the effect of a five-drug regimen, VP-16, ifosfamide, cisplatin, vinblastine, and bleomycin… 
Review
1996
Review
1996
[A case of secondary leukemia in anaplastic seminoma patient treated with long-term chemotherapy].
A 46-year-old man had received a long-term induction plus salvage chemotherapy for anaplastic seminoma with stage IV disease… 
1995
1995
Recombinant human granulocyte-macrophage colony-stimulating factor as an adjunct to conventional-dose ifosfamide-based chemotherapy for patients with advanced or relapsed germ cell tumors: a…
PURPOSE Ifosfamide-containing therapy with cisplatin plus either etoposide (VIP) or vinblastine (VeIP) can cure of patients with… 
Review
1992
Review
1992
Clinical trials with ifosfamide: the Indiana University experience.
At Indiana University, we began clinical trials with ifosfamide in 1981. Although our initial efforts were in a variety of tumor… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)